Page 24 - MI-2-3
P. 24

Microbes & Immunity                                                    Correlation between VZV and cancer



            burden but also underscore the systemic impact of VZV   2. Epidemiology of VZV
            beyond its primary manifestations.
                                                               VZV is highly contagious, primarily spreading through
              Following primary infection, viral latency occurs   respiratory droplets and direct contact with vesicular fluid
            in neurons, where it resides until reactivation, either   from skin lesions.  The contagious period for varicella
                                                                              13
            spontaneously or due to an immunocompromised state   starts 1 – 2 days before the rash appears and continues until
            in the host.  Although there are not typically any clinical   all lesions have crusted over, usually 5 days after rash onset
                     3
            symptoms that occur during the latency period, VZV may   in immunocompetent individuals.  VZV infection has
                                                                                           14
            reactivate from ganglia in the entire neuraxis, causing   been noted to follow a seasonal pattern, peaking during
            a multitude of clinical pathology.  The most common   the winter and spring months, with many environmental
                                        4
            clinical  manifestation  of  VZV  reactivation  is  a  pruritic   factors influencing its transmission. These factors include
            dermatomal rash; however, there are other infrequent and   elements such as ultraviolet radiation, which can reduce
            more serious complications that can occur if it is reactivated   the rupture of vesicles.  In addition, population density
                                                                                  15
            in the cranial nerves or if cerebral vasculature is affected.    increases contact rates, allowing for more infectivity. Both
                                                          5
            At the molecular and cellular level, it is the interaction of   of these factors taken together may explain why there is a
            VZV’s genome with the host’s immune cells, which are of   higher chance of VZV infection in temperate regions than
            particular importance in the link between VZV infection   in urban regions. 16
            and cancer development. 6                            The Centers for Disease Control and Prevention (CDC)

              The link between chickenpox and VZV was first    estimated that from 1980 to 1990, there were 4 million
            described in 1888; however, conclusive evidence proving   annual cases of varicella, with 77% of cases in children
            this connection was not established until the 1950s.    under 9 and over 90% in those under 15. Seroprevalence
                                                          7
            Although chickenpox and  HZ  have been  clinically   data from 1988 to 1994 showed that the majority of adults
            characterized from the 16  and 17  centuries, respectively,   (95.5% of those aged 20 – 29, 98.9% of those aged 30 –
                                th
                                       th
            the pathophysiology involving viral latency, reactivation   39,  and  99.6% of  those  40 and  older)  were  immune  to
                                                                      17
            triggers, and the role of the immune response in controlling   varicella.  The varicella vaccination program, introduced
            VZV  remains  poorly  understood.  This  is  partly  because   in the United States in 1996, has had a profound impact on
            VZV is a human-specific virus, limiting the use of most   the incidence and complications of varicella infections over
            animal and animal-derived neuron models. 8         the past 25 years by significantly decreasing the number of
                                                               VZV infections per year and reducing complications due
              Interestingly,  emerging  evidence  suggests  that  VZV   to infection.  Varicella-related hospitalizations and deaths
                                                                         18
            may have oncogenic potential. Previous studies have   have been reduced by 94% and 97%, respectively, among
            investigated potential links between VZV infection and the   those aged <50  years. Moreover, more than 91 million
            development of certain neoplasms, such as glioblastomas   cases of varicella, 238,000 hospitalizations, and close to
            and other malignancies, though the mechanisms      2,000 deaths were prevented during the period between
            underlying  this association  remain unclear.  It  is   1996 and 2020. 19
                                                    9
            hypothesized that chronic inflammation, immune evasion
            strategies, or viral genome integration may play a role in   During primary infection, VZV enters sensory nerve
            promoting tumorigenesis associated with VZV infection.    endings and establishes latency in the dorsal root ganglion.
                                                         10
            Others have suggested that cancer diagnosis could result   This latency period can last from 5 to 40 years or even longer.
            from immune system insufficiency, hypothesizing that a   During this time, the virus resides in a non-replicative
            weakened immune system may allow HZ to occur, which   state within the neurons of the dorsal root ganglia, cranial
                                                                                               20
            could serve as an early sign of hidden cancer. The virus   nerve  ganglia,  and  autonomic  ganglia.   Although  VZV
            may also reduce immune surveillance, enabling tumors to   latency is highly prevalent, only approximately 10 – 30%
            escape detection.  However, other studies have strongly   of individuals experience symptomatic reactivation.
                          11
                                                               This reactivation is known as HZ and presents as a
            suggested that VZV infection is not associated with occult   vesiculopapular rash along a single dermatome, which
            malignancy. 12
                                                               classically does not cross the midline.  Like primary VZV
                                                                                             21
              This  review  evaluates  the  existing  literature  on  the   infection, HZ is typically a self-limiting condition and
            association between VZV and various cancer types,   usually resolves within 2 – 4 weeks. However, HZ is most
            examining potential correlations with oncogenesis,   associated with the development of PHN, which is defined
            addressing  discrepancies  and  inconsistencies  in  the   as pain that persists for at least 90 days after the resolution
            findings, and discussing the suggested mechanisms   of the acute rash and can be debilitating, occurring in
            responsible for VZV’s potential oncogenic effects.  approximately 10 – 20% of HZ cases. 22,23  There are several


            Volume 2 Issue 3 (2025)                         16                               doi: 10.36922/mi.8320
   19   20   21   22   23   24   25   26   27   28   29